This article expands on “Tactic No. 5: Launch a counter strike at the patent office” from our previously published article…
Read More →The routine use of AI tools in organizations creates real value, but it also gives rise to privacy, information security…
Read More →Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B…
Read More →The Product Liability and Mass Tort Monitor is a monthly newsletter delivering critical updates, data insights and actionable strategies for…
Read More →On August 20, 2026, the Federal Communications Commission (“Commission”) issued a Public Notice with significant modifications to the inclusion of…
Read More →On August 20, 2026, the Federal Communications Commission (“Commission”) issued a Public Notice with significant modifications to the inclusion of…
Read More →Artificial intelligence is rapidly becoming a fixture in the boardroom. Directors are using generative AI to review and summarize materials,…
Read More →Wednesday, the FTC announced that it was seeking public comment on a newly issued Proposed Enforcement Policy Statement Regarding Personalized…
Read More →Virginia has significantly altered the tax landscape for one of its largest and fastest-growing industries by imposing a new tax…
Read More →Artificial intelligence (AI) presents an important governance challenge for boards. Directors are increasingly required to oversee the adoption and use…
Read More →